Precigen (PGEN) News Today $1.37 -0.04 (-2.84%) Closing price 04:00 PM EasternExtended Trading$1.38 +0.01 (+0.73%) As of 06:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock PGEN Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period D. E. Shaw & Co. Inc. Sells 792,731 Shares of Precigen, Inc. (NASDAQ:PGEN)D. E. Shaw & Co. Inc. decreased its holdings in Precigen, Inc. (NASDAQ:PGEN - Free Report) by 65.1% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 424,900 shares of the biotechnology company's stock after selling 792,731 shares during theMay 27 at 3:31 AM | marketbeat.comPrecigen (NASDAQ:PGEN) Rating Lowered to Sell at Wall Street ZenMay 26 at 1:59 AM | americanbankingnews.comPrecigen (NASDAQ:PGEN) Downgraded to "Sell" Rating by Wall Street ZenWall Street Zen downgraded Precigen from a "hold" rating to a "sell" rating in a research report on Saturday.May 26 at 1:50 AM | marketbeat.comFY2025 EPS Estimates for Precigen Cut by Cantor FitzgeraldPrecigen, Inc. (NASDAQ:PGEN - Free Report) - Equities researchers at Cantor Fitzgerald decreased their FY2025 earnings per share (EPS) estimates for shares of Precigen in a research note issued to investors on Thursday, May 15th. Cantor Fitzgerald analyst J. Kim now anticipates that the biotechnoMay 21, 2025 | marketbeat.comHC Wainwright Decreases Earnings Estimates for PrecigenPrecigen, Inc. (NASDAQ:PGEN - Free Report) - HC Wainwright reduced their FY2025 earnings per share (EPS) estimates for Precigen in a note issued to investors on Thursday, May 15th. HC Wainwright analyst S. Ramakanth now expects that the biotechnology company will post earnings of ($0.37) per sharMay 21, 2025 | marketbeat.comJ.P. Morgan Sticks to Its Sell Rating for Precigen (PGEN)May 20, 2025 | theglobeandmail.comAnalysts Offer Predictions for Precigen FY2025 EarningsMay 20, 2025 | americanbankingnews.comFY2025 EPS Estimates for Precigen Decreased by HC WainwrightMay 20, 2025 | americanbankingnews.comPrecigen (NASDAQ:PGEN) Receives "Overweight" Rating from Cantor FitzgeraldMay 18, 2025 | americanbankingnews.comPrecigen, Inc.: Precigen Reports First Quarter 2025 Financial Results and Business UpdatesMay 18, 2025 | finanznachrichten.deCantor Fitzgerald maintains Overweight on Precigen stockMay 17, 2025 | uk.investing.comPrecigen Reports First Quarter 2025 Financial Results and Business UpdatesMay 14, 2025 | prnewswire.comPrecigen (PGEN) Expected to Announce Earnings on TuesdayPrecigen (NASDAQ:PGEN) will be releasing its Q1 2025 earnings before the market opens on Tuesday, May 13. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-13-precigen-inc-stock/)May 8, 2025 | marketbeat.comPrecigen, Inc. (NASDAQ:PGEN) Shares Sold by Renaissance Technologies LLCRenaissance Technologies LLC cut its holdings in Precigen, Inc. (NASDAQ:PGEN - Free Report) by 33.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,067,645 shares of the biotechnology company's stock after selling 532,545 sharesMay 2, 2025 | marketbeat.comPrecigen and Recurrent Respiratory Papillomatosis Foundation to Host the 2025 International RRP Awareness Day on June 11thApril 16, 2025 | prnewswire.comIs Precigen (PGEN) The Hot Biotech Stock Under $5?March 27, 2025 | msn.comCantor Fitzgerald Comments on Precigen FY2025 EarningsPrecigen, Inc. (NASDAQ:PGEN - Free Report) - Analysts at Cantor Fitzgerald issued their FY2025 earnings per share estimates for shares of Precigen in a research report issued on Thursday, March 20th. Cantor Fitzgerald analyst J. Kim anticipates that the biotechnology company will post earnings peMarch 24, 2025 | marketbeat.comHC Wainwright Has Negative Estimate for Precigen Q1 EarningsPrecigen, Inc. (NASDAQ:PGEN - Free Report) - Stock analysts at HC Wainwright cut their Q1 2025 earnings per share estimates for shares of Precigen in a research report issued to clients and investors on Thursday, March 20th. HC Wainwright analyst S. Ramakanth now expects that the biotechnology coMarch 24, 2025 | marketbeat.comPrecigen (NASDAQ:PGEN) Stock Price Up 6.9% - What's Next?Precigen (NASDAQ:PGEN) Trading 6.9% Higher - What's Next?March 22, 2025 | marketbeat.comFY2027 EPS Estimates for Precigen Decreased by HC WainwrightPrecigen, Inc. (NASDAQ:PGEN - Free Report) - Equities researchers at HC Wainwright cut their FY2027 earnings per share (EPS) estimates for Precigen in a report released on Thursday, March 20th. HC Wainwright analyst S. Ramakanth now forecasts that the biotechnology company will post earnings of $March 22, 2025 | marketbeat.comHC Wainwright Reiterates "Buy" Rating for Precigen (NASDAQ:PGEN)HC Wainwright reiterated a "buy" rating and issued a $6.00 price objective on shares of Precigen in a report on Thursday.March 21, 2025 | marketbeat.comPrecigen options imply 20.1% move in share price post-earningsMarch 20, 2025 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Precigen (PGEN) and Edwards Lifesciences (EW)March 20, 2025 | markets.businessinsider.com4PGEN : Expert Outlook: Precigen Through The Eyes Of 4 AnalystsMarch 20, 2025 | benzinga.comPrecigen (NASDAQ:PGEN) Issues Quarterly Earnings Results, Beats Expectations By $0.02 EPSPrecigen (NASDAQ:PGEN - Get Free Report) posted its quarterly earnings results on Wednesday. The biotechnology company reported ($0.04) earnings per share for the quarter, topping analysts' consensus estimates of ($0.06) by $0.02. Precigen had a negative net margin of 3,521.68% and a negative return on equity of 123.06%.March 20, 2025 | marketbeat.comPrecigen, Inc.: Precigen Reports Full Year 2024 Financial Results and Business UpdatesMarch 20, 2025 | finanznachrichten.dePrecigen Reports Progress and Financial Results for 2024March 19, 2025 | tipranks.comPrecigen, Inc. (PGEN) Q4 2024 Earnings Call TranscriptMarch 19, 2025 | seekingalpha.comPrecigen Reports Full Year 2024 Financial Results and Business UpdatesMarch 19, 2025 | prnewswire.comPrecigen (NASDAQ:PGEN) Shares Down 4.2% - Here's WhyPrecigen (NASDAQ:PGEN) Shares Down 4.2% - Time to Sell?March 18, 2025 | marketbeat.comPrecigen to Announce Full Year 2024 Financial Results and Provide Business Updates on March 19thMarch 13, 2025 | prnewswire.comPrecigen, Inc. (NASDAQ:PGEN) Given Consensus Recommendation of "Moderate Buy" by AnalystsShares of Precigen, Inc. (NASDAQ:PGEN - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the five brokerages that are currently covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a sell rating and four have issued a buy ratinMarch 11, 2025 | marketbeat.comPrecigen (PGEN) Projected to Post Earnings on TuesdayPrecigen (NASDAQ:PGEN) will be releasing earnings before the market opens on Tuesday, March 18, Financial Modeling Prep reports.March 11, 2025 | marketbeat.comPrecigen (NASDAQ:PGEN) Shares Up 7.7% - Time to Buy?Precigen (NASDAQ:PGEN) Shares Up 7.7% - What's Next?February 28, 2025 | marketbeat.comPrecigen: UltraCAR-T Development Brings Another Side Of Pipeline AdvancementFebruary 28, 2025 | seekingalpha.comPrecigen shares surge on FDA priority review for PRGN-2012February 25, 2025 | in.investing.comPrecigen (NASDAQ:PGEN) Shares Gap Up - What's Next?Precigen (NASDAQ:PGEN) Shares Gap Up - Time to Buy?February 25, 2025 | marketbeat.comPrecigen’s BLA for PRGN-2012 in papillomatosis granted priority review by FDAFebruary 25, 2025 | markets.businessinsider.comFDA Grants Priority Review to Precigen's BLA for PRGN-2012 for the Treatment of Adults with Recurrent Respiratory Papillomatosis with PDUFA Target Action Date Set for August 27, 2025February 25, 2025 | prnewswire.comPrecigen (NASDAQ:PGEN) Hits New 1-Year High - Here's WhyPrecigen (NASDAQ:PGEN) Hits New 52-Week High - Should You Buy?February 20, 2025 | marketbeat.comPrecigen (NASDAQ:PGEN) Trading 8.4% Higher - Here's What HappenedPrecigen (NASDAQ:PGEN) Shares Up 8.4% - Should You Buy?February 19, 2025 | marketbeat.comAnalysts Set Precigen, Inc. (NASDAQ:PGEN) Price Target at $7.00Shares of Precigen, Inc. (NASDAQ:PGEN - Get Free Report) have been given an average recommendation of "Moderate Buy" by the five brokerages that are covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation and four have given a buy recommeFebruary 17, 2025 | marketbeat.comPGEN Stock Soars to 52-Week High, Reaching $1.93 Amid GrowthFebruary 13, 2025 | msn.comPrecigen (NASDAQ:PGEN) Sets New 52-Week High - Still a Buy?Precigen (NASDAQ:PGEN) Sets New 52-Week High - Here's What HappenedFebruary 12, 2025 | marketbeat.comPrecigen: Successful Proof Of Platform, But Cash Worries RemainFebruary 10, 2025 | seekingalpha.comPrecigen (NASDAQ:PGEN) Stock Price Up 7.8% - Time to Buy?Precigen (NASDAQ:PGEN) Trading 7.8% Higher - Should You Buy?February 7, 2025 | marketbeat.comIridian Asset Management LLC CT Purchases 1,465,962 Shares of Precigen, Inc. (NASDAQ:PGEN)Iridian Asset Management LLC CT increased its position in Precigen, Inc. (NASDAQ:PGEN - Free Report) by 38.8% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 5,241,922 shares of the biotechnology company's stock after purchasing an addiFebruary 7, 2025 | marketbeat.comJPMorgan Chase & Co. Decreases Stake in Precigen, Inc. (NASDAQ:PGEN)JPMorgan Chase & Co. decreased its holdings in Precigen, Inc. (NASDAQ:PGEN - Free Report) by 18.0% in the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 884,275 shares of the biotechnology company's stock after selling 194,514 shares during the quJanuary 27, 2025 | marketbeat.comFY2024 EPS Estimates for Precigen Lifted by HC WainwrightPrecigen, Inc. (NASDAQ:PGEN - Free Report) - HC Wainwright upped their FY2024 EPS estimates for shares of Precigen in a research note issued on Thursday, January 23rd. HC Wainwright analyst S. Ramakanth now expects that the biotechnology company will earn ($0.30) per share for the year, up from tJanuary 27, 2025 | marketbeat.comPrecigen's SWOT analysis: biotech firm's stock poised for growth with PRGN-2012January 24, 2025 | msn.com Get Precigen News Delivered to You Automatically Sign up to receive the latest news and ratings for PGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address PGEN Media Mentions By Week PGEN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PGEN News Sentiment▼0.151.03▲Average Medical News Sentiment PGEN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PGEN Articles This Week▼42▲PGEN Articles Average Week Get Precigen News Delivered to You Automatically Sign up to receive the latest news and ratings for PGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BHC News Today BHVN News Today SDGR News Today IMCR News Today INDV News Today EWTX News Today JANX News Today SPRY News Today BGM News Today GPCR News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PGEN) was last updated on 5/28/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe biggest threat isn’t ChinaWhile the headlines focus on AI models and chip speed, Elon Musk is investing in the material side of the stor...True Market Insiders | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Precigen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Precigen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
